Literature DB >> 2582361

Comparison of the sequence specificity of bleomycin cleavage in two slightly different DNA sequences.

V Murray, R F Martin.   

Abstract

The sequence specificity of bleomycin damage was investigated utilising 340 bp alpha-DNA (a middle repetitive sequence in the human genome) as a target sequence. The following significant facts were found:- i) The dinucleotides GT and GC were cleaved on all occasions, GA most of the time, and AT, AC, GG and AA cleaved some of the time; ii) The base immediately 5' to the purine-pyrimidine dinucleotides was found to be statistically highly significant in determining the degree of damage caused by bleomycin, while other nearest neighbour bases had no significant effect; iii) The sequence specificity of bleomycin damage was determined on both strands and it was found that damage on either strand follows the above dinucleotide preference and is independent of the extent of damage on the opposite strand; iv) Bleomycin damage was compared between genomic 340 bp alpha-DNA and a cloned alpha-DNA with eleven base substitutions relative to the "consensus" sequence. There were forty-nine detectable differences in intensity of damage between these two DNA molecules. Although four of the differences can be directly attributed to changes in base sequence, the remaining differences were not at the base substitution sites. Some of the differences were over fifty base pairs from the nearest base substitution. We propose that the majority of these differences are due to microvariation in the structure of DNA with a slightly different DNA sequence.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582361      PMCID: PMC341089          DOI: 10.1093/nar/13.5.1467

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  17 in total

1.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

2.  Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin.

Authors:  A D D'Andrea; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Sequence definition and organization of a human repeated DNA.

Authors:  J C Wu; L Manuelidis
Journal:  J Mol Biol       Date:  1980-09-25       Impact factor: 5.469

4.  Negatively supercoiled simian virus 40 DNA contains Z-DNA segments within transcriptional enhancer sequences.

Authors:  A Nordheim; A Rich
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Oxygenated iron bleomycin. A short-lived intermediate in the reaction of ferrous bleomycin with O2.

Authors:  R M Burger; S B Horwitz; J Peisach; J B Wittenberg
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

7.  Sequence relationships between single repeat units of highly reiterated African Green monkey DNA.

Authors:  R E Thayer; M F Singer; T F McCutchan
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

8.  Origin of malondialdehyde from DNA degraded by Fe(II) x bleomycin.

Authors:  R M Burger; A R Berkowitz; J Peisach; S B Horwitz
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

9.  Interaction of bleomycin with DNA.

Authors:  M Takeshita; A P Grollman; E Ohtsubo; H Ohtsubo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

10.  Use of an indicator sequence of human DNA to study DNA damage by methylbis(2-chloroethyl)amine.

Authors:  S M Grunberg; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  18 in total

1.  Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase.

Authors:  M Ponti; S M Forrow; R L Souhami; M D'Incalci; J A Hartley
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

2.  A note on sequence-dependence of DNA structure.

Authors:  A Galat
Journal:  Eur Biophys J       Date:  1990       Impact factor: 1.733

3.  The DNA sequence specificity of bleomycin cleavage in a systematically altered DNA sequence.

Authors:  Shweta D Gautam; Jon K Chen; Vincent Murray
Journal:  J Biol Inorg Chem       Date:  2017-05-16       Impact factor: 3.358

4.  Site specificity of bleomycin cleavage in purified and intracellular simian virus 40 DNA.

Authors:  J E Grimwade; E B Cason; T A Beerman
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

5.  Sequence-selective binding of phleomycin to DNA.

Authors:  K R Fox; G W Grigg; M J Waring
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

6.  Mechanistic analyses of site-specific degradation in DNA-RNA hybrids by prototypic DNA cleavers.

Authors:  M Bansal; J S Lee; J Stubbe; J W Kozarich
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

7.  Zorbamycin has a different DNA sequence selectivity compared with bleomycin and analogues.

Authors:  Jon K Chen; Dong Yang; Ben Shen; Brett A Neilan; Vincent Murray
Journal:  Bioorg Med Chem       Date:  2016-09-30       Impact factor: 3.641

8.  The degree of ultraviolet light damage to DNA containing iododeoxyuridine or bromodeoxyuridine is dependent on the DNA sequence.

Authors:  V Murray; R F Martin
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

9.  DNA structure influences sequence specific cleavage by bleomycin.

Authors:  K P Nightingale; K R Fox
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

10.  The DNA sequence specificity of bleomycin cleavage in telomeric sequences in human cells.

Authors:  Hanh T Q Nguyen; Vincent Murray
Journal:  J Biol Inorg Chem       Date:  2012-09-09       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.